BO-264

CAT: 0804-HY-135960-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-135960-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (TACC3) inhibitor with an IC50 of 188 nM and a Kd of 1.5 nM. BO-264 specifically blocks the function of FGFR3-TACC3 fusion protein. BO-264 induces spindle assembly checkpoint (SAC) -dependent mitotic arrest, DNA damage and apoptosis. BO-264 has broad-spectrum antitumor activity[1].
CAS Number
[2408648-20-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; FGFR
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bo-264.html
Purity
99.76
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
COC1=CC=C(C2=NOC(NC3=NC(N4CCOCC4)=NC=C3)=C2)C=C1
Molecular Formula
C18H19N5O3
Molecular Weight
353.38
Precautions
H302, H315, H319, H335
References & Citations
[1]Akbulut O, et al. A Highly Potent TACC3 Inhibitor as a Novel Anti-cancer Drug Candidate. Mol Cancer Ther. 2020 Mar 26. pii: molcanther.0957.2019.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117657(-) -BO 2367
HY-129805BO 1341
HY-149333BO-1
HY-118906BO-1165
HY-119899BO-0742
HY-119002BO-1236
HY-114157-01DO-264
HY-101833-01YM-264
HY-W013170-01MGK-264
HY-W953280CRBN ligand-264

Alternative Products

CatalogName
M22269-01BO-264
A22318-10BO-264 10mg
A22318-100BO-264 100mg
A22318-1BO-264 1mg
A22318-5BO-264 5mg
A22318-25BO-264 25mg
A22318-50BO-264 50mg
TBI4685-5MGBO-264, TACC3 inhibitor
A22318-10mM-DBO-264 10mM * 1mL in DMSO
MBS5776608BO 1165

Popular Products